600.20
+10.20
+(1.73%)
At close: March 3 at 8:18:52 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-420,327
-862,807
-606,812
-398,463
Investing Cash Flow
--
308,210
-461,184
-347,070
344,692
Financing Cash Flow
--
1,336,727
843,757
1,121,342
833,003
End Cash Position
--
2,048,844
800,740
1,334,676
1,216,803
Capital Expenditure
--
-43,812
-103,823
-121,434
-5,139
Issuance of Capital Stock
--
1,196,731
760,953
1,091,326
813,186
Repayment of Debt
--
-3,801
-4,165
-3,855
-2,550
Free Cash Flow
--
-464,139
-966,630
-728,246
-403,602
12/31/2020 - 3/26/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8AP.SG Agios Pharmaceuticals Inc
31.40
-4.27%
2QK.F Scholar Rock Holding Corporation
34.40
0.00%
ISI.F Ionis Pharmaceuticals, Inc.
31.80
+6.21%
ISI.MU Ionis Pharmaceuticals Inc
31.83
+4.74%
UNC.MU UCB SA
191.55
+5.71%
UCBb.XC
UCBJF UCB SA
201.97
+5.19%
VX1.F Vertex Pharmaceuticals Incorporated
466.05
+0.17%
ONTTF Oxford Nanopore Technologies plc
1.3440
-0.44%
BHVN Biohaven Ltd.
32.06
-13.77%